Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Investment in Ontario drug discovery research will help develop new cancer medicines for patients

Study points to common protein duo as a new therapeutic target for several cancer types

Unexpected mitochondria activity in leukemia cells gives opening for new treatments

OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies

OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects

Can an open drug discovery model find a solution for rare brain cancers in children?

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic